You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Belimumab

Showing 1 - 25 of 103
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus Trial (Belimumab, Standard of care)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • Standard of care
  • (no location specified)
Jun 14, 2023

cGVHD Trial in Guanzhou (Belimumab (Benlysta))

Withdrawn
  • cGVHD
  • Belimumab (Benlysta)
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023

Belimumab In Prevention of LN

Not yet recruiting
  • Whether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis
  • Belimumab
  • (no location specified)
Oct 14, 2022

Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

Recruiting
  • Lupus Nephritis
  • +2 more
  • Methylprednisolone Injectable Suspension
  • +2 more
  • Nanjing, Jiangsu, China
    Jiong Zhang
May 8, 2023

Systemic Sclerosis Associated Interstitial Lung Disease Trial (Belimumab, Placebo)

Not yet recruiting
  • Systemic Sclerosis Associated Interstitial Lung Disease
  • Belimumab
  • Placebo
  • (no location specified)
May 19, 2023

Telitacicept and Belimumab in Active Lupus Nephritis in Real

Not yet recruiting
  • Lupus Nephritis
  • +2 more
  • (no location specified)
Oct 18, 2022

SLE (Systemic Lupus) Trial in Niort (data record)

Completed
  • SLE (Systemic Lupus)
  • data record
  • Niort, France
    CH Niort
Nov 17, 2022

Lupus Erythematosus, Systemic Trial in Beijing (Belimumab, Standard of care)

Completed
  • Lupus Erythematosus, Systemic
  • Belimumab
  • Standard of care
  • Beijing, Dongcheng, China
    Peking Union Medical College hospital
Jul 5, 2022

Antiphospholipid Syndrome Trial in Turin (Belimumab)

Recruiting
  • Antiphospholipid Syndrome
  • Belimumab
  • Turin, Piedmont, Italy
    San Giovanni Bosco Hospital
May 20, 2022

Systemic Lupus Erythematosus Trial in Wilmington (belimumab)

Completed
  • Systemic Lupus Erythematosus
  • belimumab
  • Wilmington, North Carolina
  • +15 more
Jan 19, 2023

COPD, Emphysema Trial in Birmingham (Belimumab, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Emphysema
  • Belimumab
  • Placebo
  • Birmingham, Alabama
    UAB Lung Health Center
Apr 4, 2022

Lupus Erythematosus, Systemic, Lupus Erythematosus Trial in Manhasset (Belimumab, Belimumab/Placebo, Placebo)

Recruiting
  • Lupus Erythematosus, Systemic
  • Lupus Erythematosus
  • Belimumab
  • +2 more
  • Manhasset, New York
    Feinstein Institute
Dec 2, 2021

Systemic Lupus Erythematosus Trial in Beijing (Belimumab, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Mar 24, 2022

Systemic Lupus Erythematosus Trial (Belimumab)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • (no location specified)
Jan 12, 2022

Primary Immune Thrombocytopenia (ITP) Trial (Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Combination of Rituximab with subcutaneous belimumab
  • Combination of Rituximab with subcutaneous placebo
  • (no location specified)
Apr 15, 2022

Chronic Lymphoid Leukemia in Relapse Trial in Tuebingen (Belimumab 200 MG/ML [Benlysta], standard of care)

Recruiting
  • Chronic Lymphoid Leukemia in Relapse
  • Belimumab 200 MG/ML [Benlysta]
  • standard of care
  • Tuebingen, BW, Germany
    University Hospital Tuebingen, CCU Translational Immunology
Feb 2, 2022

Systemic Lupus Erythematosus Trial in SIngapore (Belimumab Injection [Benlysta])

Recruiting
  • Systemic Lupus Erythematosus
  • Belimumab Injection [Benlysta]
  • SIngapore, Singapore
    National University Hospital
Dec 2, 2021

Membranous Nephropathy, Nephrotic Syndrome Trial in Canada, United States (Belimumab, Placebo for Belimumab, Rituximab)

Recruiting
  • Membranous Nephropathy
  • Nephrotic Syndrome
  • Belimumab
  • +2 more
  • Birmingham, Alabama
  • +16 more
Sep 22, 2022

ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)

Active, not recruiting
  • ANCA Associated Vasculitis
  • Granulomatosis With Polyangiitis
  • Belimumab
  • +2 more
  • Cambridge, United Kingdom
  • +5 more
Feb 21, 2022

Systemic Lupus Erythematosus Trial in Shanghai (Belimumab, Placebo)

Recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • Placebo
  • Shanghai, Shanghai, China
    Shuang Ye, MD
Sep 27, 2021

Lupus Erythematosus, Systemic Trial in Netherlands (Belimumab Injection)

Recruiting
  • Lupus Erythematosus, Systemic
  • Belimumab Injection
  • Groningen, Netherlands
  • +3 more
Mar 14, 2022

Systemic Lupus Erythematosus Trial (Belimumab, Standard therapy)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Belimumab
  • Standard therapy
  • (no location specified)
Sep 29, 2021

Multiple Sclerosis Trial in Baltimore (Belimumab, Short-course Ocrelizumab, Continued Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Belimumab
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 7, 2021

Systemic Lupus Erythematosus and Rheumatoid Arthritis

Recruiting
  • Systemic Lupus Erythematosus
  • +2 more
  • Belimumab in SLE patients / Rituximab in RA patients
  • Monserrato, Cagliari, Italy
    Matteo Piga
Dec 13, 2022

IgG4-related Disease Trial in Beijing (Prednisone and Belimumab, Prednisone)

Recruiting
  • IgG4-related Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 6, 2021